Compounds > cysteamine
Page last updated: 2024-08-17

cysteamine and cyclosporine

cysteamine has been researched along with cyclosporine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bernton, E; Bryant, H; Dave, J; Holaday, J1
Goldstone, SD; Hunt, NH1

Reviews

1 review(s) available for cysteamine and cyclosporine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for cysteamine and cyclosporine

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A.
    Brain, behavior, and immunity, 1992, Volume: 6, Issue:4

    Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Corticosterone; Cyclosporine; Cysteamine; Glucocorticoids; Hemolytic Plaque Technique; Lymphocyte Activation; Male; Metoclopramide; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Perphenazine; Pituitary-Adrenal System; Prolactin; Spleen

1992
Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation.
    Biochimica et biophysica acta, 1997, Mar-01, Volume: 1355, Issue:3

    Topics: Alkaloids; Antioxidants; Benzophenanthridines; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cyclosporine; Cysteamine; DNA-Binding Proteins; Humans; Interphase; Ionomycin; Jurkat Cells; Lymphocyte Activation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Monocytes; Phenanthridines; Reactive Oxygen Species; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription Factor AP-1

1997